glutathione iron deficiency Release of ROS during deficiency, dyslipidemia, hypertension, Biochemistry & Physiology: Open Access

Potential therapies With the deepening understanding of the pathological mechanisms underlying PD, current therapeutic strategies have shifted from purely dopaminergic replacement toward disease-modifying interventions targeting core pathological processes

The infusion of antioxidants and amino acids further aids in reducing oxidative stress and promoting tissue repair, crucial for maintaining mobility and daily functioning

While some genetically modified OVs are engineered to enhance tumor specificity and therapeutic efficacy, others are naturally oncotropic, meaning they inherently exhibit tumor-selective tropism without genetic modification

*Correspondence: Zhenzhuang Zou, [email protected]